締碼生物科技有限公司是一個(ge) 專(zhuan) 注於(yu) 腫瘤免疫產(chan) 品和服務的重組單克隆抗體(ti) 研發公司。公司擁有的DimAb®重組單克隆抗體(ti) 技術，可以獲得多種屬、高質量的單克隆抗體(ti) 。公司研發團隊具備多年的單克隆抗體(ti) 開發經驗，並獲得業(ye) 界廣泛認可。公司致力於(yu) 腫瘤免疫靶標單克隆抗體(ti) 的研發和生產(chan) ，為(wei) 全球的科學研究、臨(lin) 床診斷和藥物研發提供方位的解決(jue) 方案。 公司的企業(ye) 文化是誠信，務實，創新，專(zhuan) 注。公司的使命是應用先進的生物技術為(wei) 癌症的診斷和治療提供全新有效的解決(jue) 方案。
dimabio2021年價(jia) 格表
| 貨號 | 品名 | 規格 | 價格 | 品牌 |
| DME100001 | Anti-His Tag Antibody(DM1), Rabbit mAb | 100 μl | 2680 | dimabio2021 |
| DME100004 | Anti-BCMA antibody(DM4), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100006 | Anti-BCMA antibody(DM6), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100008 | Anti-SIRPα antibody(DM8) , Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100009 | Anti-CS1 antibody(DM9)， Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100010 | Anti-CS1 antibody(DM10)， Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100011 | Anti-CS1 antibody(DM11)， Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100013 | Anti-CD22 antibody(DM13), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100015 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM22), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100016 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM23), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100017 | Anti-SARS-CoV-2 Spike S2 antibody(DM24), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100018 | Anti-SARS-CoV-2 Spike S2 antibody(DM25), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100025 | Anti-SARS-CoV-2 RBD antibody(DM26), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100026 | Anti-SARS-CoV-2 RBD antibody(DM27), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100020 | Anti-BCMA antibody(DM16), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100027 | Anti-CD38 antibody(DM28), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100028 | Anti-CD38 antibody(DM29), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100029 | Anti-CD38 antibody(DM30), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100034 | Anti-SARS-CoV-2 RBD antibody(DM35), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100030 | Anti-CD123 antibody(DM31), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100032 | Anti-CD123 antibody(DM33), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100033 | Anti-CD123 antibody(DM34), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100035 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM36), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100036 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM37), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100037 | Anti-SARS-CoV-2 Nucleocapsid antibody(DM38), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100038 | Anti-SARS-CoV-2 Spike antibody(DM39), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100039 | Anti-SARS-CoV-2 Spike antibody(DM40), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100040 | Anti-SARS-CoV-2 Spike antibody(DM41), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100041 | Anti-SARS-CoV-2 Spike antibody(DM42), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100042 | Anti-CD48 antibody(DM43), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100043 | Anti-CD48 antibody(DM44), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100044 | Anti-CD138 antibody(DM45), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100045 | Anti-CD138 antibody(DM46), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100046 | Anti-ACE2 antibody(DM47), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100047 | Anti-ACE2 antibody(DM48), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100048 | Anti-CD47 antibody(DM49), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100049 | Anti-CTLA4 antibody(DM50), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100050 | Anti-CTLA4 antibody(DM51), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100052 | Anti-GITR-L antibody(DM52), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100053 | Anti-B7-H3 antibody(DM53), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100057 | Anti-CD27 antibody(DM57), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100058 | Anti-CD27 antibody(DM58), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100059 | Anti-CD27 antibody(DM59), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100060 | Anti-GPRC5D antibody(DM60), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100061 | Anti-GPRC5D antibody(DM61), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100062 | Anti-GPRC5D antibody(DM62), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100063 | Anti-CD28 antibody(DM63), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100064 | Anti-CD28 antibody(DM64), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100069 | Anti-2B4 antibody(DM69), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100054 | Anti-SARS-CoV-2 RBD antibody(DM54), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100055 | Anti-SARS-CoV-2 RBD antibody(DM55), Rabbit mAb | 100 μl | 3180 | dimabio2021 |
| DME100056 | Anti-CD138 antibody(DM56), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100068 | Anti-4-1BB Ligand antibody(DM68), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100070 | Anti-2B4 antibody(DM70), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100071 | Anti-MSLN antibody(DM71), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100072 | Anti-MSLN antibody(DM72), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100073 | Anti-MSLN antibody(DM73), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100066 | Anti-4-1BB antibody(DM66), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100067 | Anti-4-1BB antibody(DM67), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100074 | Anti-Trop2 antibody(DM74), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100075 | Anti-Trop2 antibody(DM75), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100076 | Anti-Trop2 antibody(DM76), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100077 | Anti-CD33 antibody(DM77), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100078 | Anti-GITR antibody(DM78), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100079 | Anti-GITR antibody(DM79), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100080 | Anti-GITR antibody(DM80), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100084 | Anti-B7-2 antibody(DM84), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100085 | Anti-B7-2 antibody(DM85), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100086 | Anti-B7-2 antibody(DM86), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100087 | Anti-PSCA antibody(DM87), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100088 | Anti-NKp30 antibody(DM88), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100081 | Anti-TIM3 antibody(DM81), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100082 | Anti-TIM3 antibody(DM82), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100083 | Anti-TIM3 antibody(DM83), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100089 | Anti-GPRC5D antibody(DM89), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| DME100090 | Anti-GPRC5D antibody(DM90), Rabbit mAb | 100 μl | 3880 | dimabio2021 |
| BME100001 | Anti-CD47 (magrolimab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100002 | Anti-CS1 (elotuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100003 | Anti-CD123 (talacotuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100004 | Anti-CD38 (daratumumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100005 | Anti-CD70 (vorsetuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100006 | Anti-PD-1 (pembrolizumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100007 | Anti-IL6 (siltuximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100008 | Anti-TIM3 (cobolimab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100009 | Anti-PDL1 (atezolizumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100010 | Anti-B7-H3 (enoblituzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100011 | Anti-SARS-CoV-2 (CB6 biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100012 | Anti-ICOS (vopratelimab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100013 | Anti-SARS-CoV (CR3022) mAb | 100 μl | 1500 | dimabio2021 |
| BME100014 | Anti-CD138 (indatuximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100015 | Anti-CD33 (gemtuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100018 | Anti-CD27 (varlilumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100019 | Anti-EPHA3 (ifabotuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100016 | Anti-BCMA mAb | 100 μl | 1500 | dimabio2021 |
| BME100017 | Anti-CD30 (brentuximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100020 | Anti-CD40 (iscalimab biosesimilar)mAb | 100 μl | 1500 | dimabio2021 |
| BME100021 | Anti-MSLN(amatuximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100022 | Anti-CTLA4 (ipilimumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100023 | Anti-Trop2 (sacituzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100024 | Anti-TIGIT (etigilimab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100038 | Anti-IL17RA (brodalumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100039 | Anti-NKG2D (tesnatilimab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100040 | Anti-CA9 (girentuximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100025 | Anti-CD20 (rituximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100026 | Anti-TIGIT (tiragolumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100027 | Anti-TIGIT (vibostolimab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100028 | Anti-BCMA ( belantamab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100034 | Anti-EGFR (Cetuximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100033 | Anti-AXL (enapotamab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100032 | Anti-TNFRSF10B (tigatuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100031 | Anti-TweakR (enavatuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100030 | Anti-CD52 (alemtuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100029 | Anti-CD22 (pinatuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100035 | Anti-CEACAM5 (labetuzumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100036 | Anti-ICAM1 (bersanlimab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100037 | Anti-4-1BB (utomilumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100041 | Anti-IL6R (tocilizumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100042 | Anti-CD40L (ruplizumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100043 | Anti-IL2RA (basiliximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100044 | Anti-BAFF (belimumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100045 | Anti-BAFFR (ianalumab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
| BME100046 | Anti-CD37 (naratuximab biosesimilar) mAb | 100 μl | 1500 | dimabio2021 |
電話
QQ掃一掃
